Lateral Retinacular Release in Primary Total Knee Arthroplasty.
10.4055/jkoa.2002.37.5.617
- Author:
Woo Shin CHO
1
;
Jong Hi PARK
;
Woo Yeon HWANG
;
Sung Chan AHN
;
Bum Sik LEE
Author Information
1. Department of Orthopedic Surgery, Asan Medical Center, College of Medicine, Ulsan University, Seoul, Korea. wscho@www.amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Patellofemoral tracking;
Lateral retinacular release;
Primary total knee arthroplasty
- MeSH:
Arthroplasty*;
Follow-Up Studies;
Knee*;
Range of Motion, Articular
- From:The Journal of the Korean Orthopaedic Association
2002;37(5):617-621
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To determine the effect of lateral retinacular release on patellofemoral alignment in primary total knee arthroplasty (TKA). MATERIALS AND METHODS: From June 1990 to December 1998, 351 cases of TKA, which were followed up more than 3 years, were divided into two groups, 147 cases (group I) with lateral retinacular release and 204 cases (group II) were without release. We compared the two groups in terms of the range of motion, patellofemoral alignment and clinical results using a Hospital for Special Surgery score. RESULTS: Average range of motion in group I (112 degrees preoperatively and 113 degrees on final follow-up) and group II (114 degrees preoperatively and 113 degrees on final follow-up) showed no statistical difference. The average functional knee score in group I (58 preoperatively and 88 on final follow-up) and group II (59 and 85 respectively) also showed no statistical difference. Patellar maltracking occurred in 4 cases (2.7%) in group I and 31 cases (15.2%) in group II. Patellar tilting (4.5 degrees in group I and 7.7 degrees in group II) and patellar translation (3.7 mm in group I and 7.8 mm in group II) showed significant statistical difference between the two groups at the final follow-up. CONCLUSION: Patellar tracking was better in the lateral retinacular release group, although there was no clinically significant difference at the short term follow-up period.